January 17, 2018

Selexis SA Appoints Alberto Garotti as Chief Financial Officer

Read More
January 05, 2018

Selexis SA to Participate at Several Upcoming Industry Conferences

Read More
December 20, 2017

Selexis SA and Turgut Pharmaceuticals Advance Partnership with Third Commercial License Agreement

Read More
October 04, 2017

Selexis SA and Pelican Therapeutics Sign Agreement to Advance Pelican’s Immunotherapy Clinical Programs

Read More
September 26, 2017

Selexis SA and OSE Immunotherapeutics Expand Strategic Alliance to Further Advance OSE’s OSE-172 and OSE-703 Cancer Immunotherapy Programs

Read More